[Pharmacotherapy of alcohol withdrawal: update and new developments].

Der Nervenarzt
Michael Soyka, Susanne Rösner

Abstract

So far few medications are approved for prophylactic treatment of alcohol dependence relapse. Apart from disulfiram, which is no longer marketed in Germany, the opioid antagonists naltrexone, nalmefene and the putative glutamate antagonist acamprosate are approved. In some other countries, baclofen and gamma-hydroxybutyrate (GHB) are licensed. Possible other drugs of interest for prophylaxis of alcohol dependence relapse are vareniclin, gabapentin, and topiramate, but so far none of them have received approval. In the light of the currently running revision of the German guidelines for the diagnosis and treatment of alcohol related disorders, an update on the pharmacotherapy of alcohol dependence is presented.

References

Nov 1, 1992·Archives of General Psychiatry·J R VolpicelliC P O'Brien
Nov 1, 1992·Archives of General Psychiatry·S S O'MalleyB Rounsaville
Aug 1, 1988·British Journal of Addiction·G EdwardsA Duckitt
Oct 1, 1994·Addiction·E J MarshallC Taylor
Sep 10, 2002·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Giovanni AddoloratoGiovanni Gasbarrini
Dec 15, 2004·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Olivier Ameisen
Apr 7, 2005·JAMA : the Journal of the American Medical Association·James C GarbuttUNKNOWN Vivitrex Study Group
May 4, 2006·JAMA : the Journal of the American Medical Association·Raymond F AntonUNKNOWN COMBINE Study Research Group
Jul 29, 2010·Alcoholism, Clinical and Experimental Research·James C GarbuttBarbara A Flannery
Aug 17, 2010·Drug and Alcohol Dependence·Marilyn D SkinnerHenri-Jean Aubin
Mar 19, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Giovanni AddoloratoUNKNOWN Baclofen Study Group
May 17, 2011·Alcoholism, Clinical and Experimental Research·Henning KrampeHannelore Ehrenreich
Feb 3, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Stefan LeuchtJohn M Davis
Apr 9, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Antoni GualUNKNOWN ESENSE 2 Study Group
Jun 4, 2013·Journal of Addiction Medicine·Raye Z LittenUNKNOWN NCIG (National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group) Study Group
Jul 23, 2013·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Wim van den BrinkKarl Mann
Aug 16, 2013·The Journal of Clinical Psychiatry·Taro KishiChristoph U Correll
Oct 2, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Rainer SpanagelFalk Kiefer
Jan 17, 2014·Alcoholism, Clinical and Experimental Research·Jürgen RehmBridget Grant
Feb 13, 2014·PloS One·Marilyn D SkinnerHenri-Jean Aubin
Feb 15, 2014·The American Journal of Psychiatry·Henry R KranzlerKyle M Kampman
May 3, 2014·The International Journal of Neuropsychopharmacology·Henry R KranzlerJonathan Covault
May 7, 2014·Alcoholism, Clinical and Experimental Research·Janet C BlodgettJohn W Finney
May 16, 2014·JAMA : the Journal of the American Medical Association·Daniel E JonasJames C Garbutt
Sep 24, 2014·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·K C MorleyP S Haber
May 8, 2015·Pharmacogenomics·Daniel Jo Roche, Lara A Ray
Jun 7, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Christian A MüllerAndreas Heinz
Jun 23, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Benjamin RollandOlivier Cottencin
Aug 13, 2015·Pharmacogenomics·Isabelle E BauerDavid A Nielsen
Sep 29, 2015·Alcoholism, Clinical and Experimental Research·Andrea de BejczyBo Söderpalm
Jan 27, 2016·Expert Opinion on Pharmacotherapy·Michael Soyka
Mar 30, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Julia M A SinclairDavid S Baldwin
Aug 19, 2016·BMC Medicine·Florian NaudetBruno Laviolle
Nov 16, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Esther M BerahaReinout W Wiers

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
Sedation

Software Mentioned

ALITA
COMBINE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Studies on Alcohol and Drugs. Supplement
Leah R Zindel, Henry R Kranzler
Expert Opinion on Pharmacotherapy
Christian A MüllerAndreas Heinz
Current Opinion in Neurobiology
Johan Franck, Nitya Jayaram-Lindström
Fundamental & Clinical Pharmacology
Sophie Tambour, Etienne Quertemont
© 2021 Meta ULC. All rights reserved